Heron Therapeutics Earning Date (HRTX)

USA |NASDAQ |USD

HRTX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 8, 2022 Jun 2022 $-0.50 $-0.63 $-0.62
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 8, 2022 Jun 2022 $24.31M $23.46M $22.44M

Heron Therapeutics's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.

HRTX Earnings Date & History Chart

HRTX Earnings & Revenue Forecast

HRTX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 5 $-0.50 $-0.59 $-0.37
Sep 2022 5 $-0.46 $-0.52 $-0.32
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $-1.98 $-2.20 $-1.57
Dec 2023 5 $-1.18 $-1.51 $-1.01

HRTX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 2 / 3 $-0.44 $-0.41 $-0.44
Sep 2022 1 / 3 $-0.41 $-0.37 $-0.44
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $-1.72 $-1.72 $-1.96
Dec 2023 0 / 0 $-0.86 $-0.79 $-0.87

HRTX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 4 $24.31M $24.10M $24.75M
Sep 2022 4 $27.53M $26.50M $28.57M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $106.69M $106.20M $107.69M
Dec 2023 4 $166.99M $153.67M $175.00M

HRTX Earnings Date & Revenue History

HRTX Earnings History

|
Show More
Show More

HRTX Revenue History

|
Show More
Show More

Heron Therapeutics Next Earnings Date & Report

HRTX Next Earnings Date & Report Preview: Jun 2022 (FQ)

HRTX's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.

According to 5 analysts, the average EPS estimation for Heron Therapeutics's next quarterly earnings is $-0.50, with a low EPS estimation of $-0.59, and a high estimation of $-0.37.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 3 downward. The EPS 1 month trend is $-0.44, the last 2 month trend is $-0.41, and the 3 month trend is $-0.44.

Based on 5 analysts, the average revenue estimation is $24.31M, with a low revenue estimation of $24.10M, and a high estimation of $24.75M.

Heron Therapeutics Previous Earnings Dates & Reports

HRTX Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Heron Therapeutics's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

HRTX's earnings per share (EPS) was $-0.63, missing the consensus analysts forecast of $-0.48 by -31.25%.

The EPS was lower than the previous fiscal quarter (Dec 2021) by 16.67%, and lower than the same period a year before (Mar 2021) by 8.62%.

Revenues were $23.46M, better than the forecast of $22.61M by 3.75%, up by 9.16% from the previous quarter , and up by 17.18% from the same period last year.

The company reported a net income of $-63.89M.

Free cash flow for the quarter was $-44.98M , compared to $-42.15M last quarter and $-42.72M a year before.

HRTX ended the quarter with $159.01M in total debt, an increase of 3.31% compared to the previous quarter, and an increase of 550.97% compared to the same quarter a year before.

HRTX Previous Earnings Date & Report Recap: Dec 2021 (FY)

Heron Therapeutics's previous annual earnings date was Feb 28, 2022 for its fiscal year ended Dec 31, 2021.

HRTX's earnings per share (EPS) was $-2.25, beating the consensus analysts forecast of $-2.28 by -1.32% , and higher than the previous year's EPS (Dec 2020) by -10.00%.

Revenues were $87.18M, worse than the forecast of $91.79M by -5.02%, and down by -1.65% from previous year's revenue.

The company reported a net income of $-220.68M.

Heron Therapeutics reported a free cash flow of $-202.88M for its fiscal year, compared to $-191.63M a year ago.

The company ended the fiscal year with $153.92M in total debt, an increase of 525.40% compared to the previous year.